Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Cardiovascular Intervention
Impact of Rotational Atherectomy on Heavily Calcified, Unprotected Left Main Disease
– The New Tokyo Registry –
Hiroto YabushitaKensuke TakagiSatoko TaharaYusuke FujinoTakayuki WarisawaHiroyoshi KawamotoYusuke WatanabeSatoru MitomoKenichi KarubeTakahiro MatsumotoTomohiko SatoToru NaganumaTsuyoshi KobayashiHisaaki IshiguroKeiko FukinoNaoyuki KuritaShotarou NakamuraKoji HozawaSunao Nakamura
Author information

2014 Volume 78 Issue 8 Pages 1867-1872


Background:There is little data on percutaneous coronary intervention (PCI) using rotational atherectomy (Rota) for severely calcified unprotected left main (ULM) lesions.Methods and Results:Between January 2005 and August 2011, 64 consecutive patients who underwent drug-eluting stent implantation using Rota were retrospectively evaluated. Of these, 54.7% and 20.3% patients had diabetes and were undergoing hemodialysis (HD), respectively. The mean EuroSCORE and SYNTAX score was 5.6 and 35.4, respectively. Procedural success, defined as residual stenosis <30%, was achieved in 95.3% of patients without fatal complications. Periprocedural myocardial infarction occurred in 7.8% patients. At the 1-year follow up, cardiac death was observed in 6.3% of patients, and target lesion revascularization (TLR) and TLR in the main branch (TLR-MB) were required in 18.8% and 10.9% patients, respectively. Optimal stent expansion was achieved in the majority of 33 patients with available intravascular ultrasound (IVUS) data. However, 5 of 9 HD patients who underwent IVUS required TLR-MB despite optimal stent expansion. The rate of TLR-MB was significantly lower in the non-HD patients than in the HD patients (2.1% vs. 46.2%; P=0.003).Conclusions:PCI using Rota for calcified ULM lesions might guarantee high procedural success and a low complication rate. Although acceptable results were obtained at the 1-year follow up for non-HD patients, the rate of TLR-MB was considerably high for HD patients despite optimal stent expansion. (Circ J 2014; 78: 1867–1872)

Information related to the author
Previous article Next article